Patents by Inventor Gudrun KOCH

Gudrun KOCH has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Yellow luminophore and light source
    Patent number: 11920071
    Abstract: A luminophore having the general empirical formula X?1?xA?y(Al1+zA?3?z)O4:E? that crystallizes in a tetragonal crystal system. X? may be Mg, Ca, Sr, Ba, and combinations thereof; A? may be Li, Na, K, Rb, Cs, and combinations thereof; E? may be Eu, Ce, Yb, Mn, and combinations thereof; 0<x<0.25; y?x; and z=0.5(2x?y).
    Type: Grant
    Filed: June 4, 2020
    Date of Patent: March 5, 2024
    Assignee: OSRAM Opto Semiconductors GmbH
    Inventors: Daniel Bichler, Simon Dallmeir, Christian Koch, Simon Peschke, Gudrun Plundrich, Philipp Schmid, Christiane Stoll, Johanna Strube-Knyrim, Jutta Thoma, Mark Vorsthove
  • CONJUGATED DEOXYNIVALENOL TO PROTECT AGAINST MYCOTOXICOSIS
    Publication number: 20220233496
    Abstract: The present invention pertains to the use of conjugated deoxynivalenol (DON) in a method to protect an animal against DON induced mycotoxicosis, in particular to protect against a decrease in average daily weight gain, liver damage, stomach ulcers and/or kidney damage as a result of the ingestion of DON.
    Type: Application
    Filed: July 2, 2020
    Publication date: July 28, 2022
    Applicant: Intervet Inc.
    Inventors: Sietske Kooijman, Rudd Philip Antoon Maria Segers, Mateusz Walczak, Gudrun Koch, Maarten Hendrik Witlvliet
  • USE OF STATINS IN OVERCOMING RESISTANCE TO BETA-LACTAM ANTIBIOTICS IN BACTERIAL SPECIES SYNTHETIZING ISOPRENOIDS USING THE MEVALONATE SYNTHETIC PATHWAY
    Publication number: 20200345701
    Abstract: The present invention relates to a beta-lactam antibiotic for use in a method of treating a bacterial infection in a subject in need thereof wherein said bacterial infection is caused by a bacterial species characterized by using the mevalonate synthetic pathway, wherein said subject is further treated, before or simultaneously to said beta-lactam antibiotic, with a statin, wherein said statin is for use in reducing, mitigating or reversing resistance to said beta-lactam antibiotic in resistant bacterial populations of said bacterial species.
    Type: Application
    Filed: November 2, 2018
    Publication date: November 5, 2020
    Inventors: Daniel LÓPEZ SERRANO, Gudrun KOCH